Novel Therapeutic Agents in Phase 2b or Later for Moderate-to-Severe Chronic and Neuropathic Pain
Preventive or disease modifying agents for pain chronification
Novel therapeutic agents and compounds with proof ‐ of ‐ concept data (Phase 2 or later) that are significantly differentiated from standard of care in safety and efficacy
Biomarkers and diagnostics
Biomarkers and genetic markers for pain chronification
